Home > Insider Trading > Filing (0001144204-10-055794)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1059784	Generex Biotechnology Corp	GNBT	Pharmaceutical Preparations (2834)	820490211

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1125858	C Rose Perri	33 Harbour Square, Suite 202 Toronto A6 M5J 2G2	Coo, Cfo& Treas.	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-27	54,000	$0.35	458,726	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,451,246	Indirect	By Estate of Mark Perri
Common Stock	341,496	Indirect	By EBI, Inc.
Common Stock	953,667	Indirect	By GHI, Inc.
Common Stock	953,667	Indirect	By GHI, Inc.

Footnotes

This aggregate number of shares does not include 200,000 shares of common stock underlying stock options which survived the death of Mark Perri, who was the reporting person's brother.
The reporting person may be deemed to beneficially own such 341,496 shares owed of record by EBI, Inc. because the reporting person holds the right to vote such shares.
The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. by reason of the reporting person's ownership of investment power and other economic benefits associated with such shares.
The reporting person may be deemed to beneficially own such 953,667 shares owned of record by GHI, Inc. because the reporting person holds the right to vote such shares.